Annual SG&A:
$76.59M+$1.64M(+2.19%)Summary
- As of today, RLAY annual SG&A is $76.59 million, with the most recent change of +$1.64 million (+2.19%) on December 31, 2024.
- During the last 3 years, RLAY annual SG&A has risen by +$19.21 million (+33.47%).
- RLAY annual SG&A is now at all-time high.
Performance
RLAY SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$12.13M-$1.50M(-10.99%)Summary
- As of today, RLAY quarterly SG&A is $12.13 million, with the most recent change of -$1.50 million (-10.99%) on September 30, 2025.
- Over the past year, RLAY quarterly SG&A has dropped by -$7.62 million (-38.59%).
- RLAY quarterly SG&A is now -39.77% below its all-time high of $20.14 million, reached on June 30, 2024.
Performance
RLAY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$7.40B-$297.59M(-4.19%)Summary
- As of today, RLAY TTM SG&A is -$7.40 billion, with the most recent change of -$297.59 million (-4.19%) on September 30, 2025.
- Over the past year, RLAY TTM SG&A has dropped by -$7.48 billion (-9778.05%).
- RLAY TTM SG&A is now -3804.99% below its all-time high of -$189.48 million.
Performance
RLAY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
RLAY Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +2.2% | -38.6% | -9778.0% |
| 3Y3 Years | +33.5% | -24.5% | -10000.0% |
| 5Y5 Years | +457.4% | -0.8% | -10000.0% |
RLAY Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +33.5% | -39.8% | at low | -111.6% | at low |
| 5Y | 5-Year | at high | +457.4% | -39.8% | at low | -582.3% | at low |
| All-Time | All-Time | at high | +765.0% | -39.8% | +295.5% | -3805.0% | at low |
RLAY Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $12.13M(-11.0%) | $61.40M(-11.0%) |
| Jun 2025 | - | $13.63M(-27.3%) | $69.02M(-8.6%) |
| Mar 2025 | - | $18.74M(+10.9%) | $75.53M(-1.4%) |
| Dec 2024 | $76.59M(+2.2%) | $16.90M(-14.4%) | $76.59M(+0.2%) |
| Sep 2024 | - | $19.75M(-1.9%) | $76.45M(+1.7%) |
| Jun 2024 | - | $20.14M(+1.7%) | $75.19M(+0.0%) |
| Mar 2024 | - | $19.80M(+18.1%) | $75.17M(+0.3%) |
| Dec 2023 | $74.95M(+13.6%) | $16.77M(-9.3%) | $74.95M(+0.5%) |
| Sep 2023 | - | $18.48M(-8.1%) | $74.56M(+3.3%) |
| Jun 2023 | - | $20.12M(+2.8%) | $72.14M(+3.8%) |
| Mar 2023 | - | $19.58M(+19.6%) | $69.49M(+5.3%) |
| Dec 2022 | $65.98M | $16.37M(+1.8%) | $65.98M(+1.3%) |
| Sep 2022 | - | $16.07M(-8.0%) | $65.15M(+2.2%) |
| Jun 2022 | - | $17.46M(+8.7%) | $63.76M(+5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $16.07M(+3.4%) | $60.72M(+5.8%) |
| Dec 2021 | $57.39M(+48.7%) | $15.55M(+5.9%) | $57.39M(+0.0%) |
| Sep 2021 | - | $14.68M(+1.8%) | $57.38M(+4.5%) |
| Jun 2021 | - | $14.42M(+13.2%) | $54.93M(+18.0%) |
| Mar 2021 | - | $12.73M(-18.1%) | $46.56M(+20.7%) |
| Dec 2020 | $38.59M(+180.8%) | $15.54M(+27.1%) | $38.59M(+45.8%) |
| Sep 2020 | - | $12.23M(+102.1%) | $26.47M(+48.0%) |
| Jun 2020 | - | $6.05M(+27.2%) | $17.89M(+16.6%) |
| Mar 2020 | - | $4.76M(+38.9%) | $15.34M(+12.4%) |
| Dec 2019 | $13.74M(+55.2%) | $3.43M(-6.2%) | $13.65M(+33.5%) |
| Sep 2019 | - | $3.65M(+4.1%) | $10.23M(+55.5%) |
| Jun 2019 | - | $3.51M(+14.4%) | $6.58M(+114.4%) |
| Mar 2019 | - | $3.07M | $3.07M |
| Dec 2018 | $8.86M | - | - |
FAQ
- What is Relay Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. annual SG&A year-on-year change?
- What is Relay Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Relay Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Relay Therapeutics, Inc.?
- What is Relay Therapeutics, Inc. TTM SG&A year-on-year change?
What is Relay Therapeutics, Inc. annual SG&A?
The current annual SG&A of RLAY is $76.59M
What is the all-time high annual SG&A for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high annual SG&A is $76.59M
What is Relay Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, RLAY annual SG&A has changed by +$1.64M (+2.19%)
What is Relay Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of RLAY is $12.13M
What is the all-time high quarterly SG&A for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high quarterly SG&A is $20.14M
What is Relay Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, RLAY quarterly SG&A has changed by -$7.62M (-38.59%)
What is Relay Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of RLAY is -$7.40B
What is the all-time high TTM SG&A for Relay Therapeutics, Inc.?
Relay Therapeutics, Inc. all-time high TTM SG&A is -$189.48M
What is Relay Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, RLAY TTM SG&A has changed by -$7.48B (-9778.05%)